12 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
to the collaborative culture among board members, knowledge of our business and understanding of the competitive landscape.
The following Board Diversity
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
have been issued.
We have developed technology to collect large volumes of Treg exosomes from the tissue culture media that is utilized in the Treg … model involves co-culture of primary human hepatocytes, Kupffer cells, liver endothelial cells, and stellate cells and was evaluated across multiple
424B4
neknj851 nev
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
jf6rc
5 Dec 22
IPO registration (amended)
8:16am
S-1
uenw00b083 gka1n3
18 Nov 22
IPO registration
5:06pm
DRS/A
3aahk46q
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
dx7a141dhd493 5chu0w
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
ih69c9br rgi
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next